Asian Myeloma Network | International Myeloma Foundation

Week in Review

June 26

May and June 2025: What's New in Myeloma? 

Week in Review

October 24

Highlights of the 8th Annual Asian Myeloma Network (AMN) Summit in Seoul, South Korea

$Randomized Phase III Study of Pomalidomide Cyclophosphamide Dexamethasone (PCd) Versus Pomalidomide Dexamethasone (Pd) in Relapse or Refractory Myeloma: An Asian Myeloma Network (AMN) Study Presented at ASH 2023$

ASH

January 4

Optimizing Myeloma Treatment: Pomalidomide-based Regimens Compared in Asian Myeloma Network (AMN) Study — a Phase III Analysis of PCd vs. Pd for Relapse or Refractory Myeloma (RRMM)

Week in Review

November 16

Prepare for an Intense and Exciting ASH 2023

231026 Dr. Durie blog on Asian Myeloma Summit

Week in Review

October 26

Progress in Asia Helps Myeloma Patients Everywhere

What is the IMF's Asian Myeloma Network? | Enhancing myeloma care in Asia and globally.

Ask Dr. Durie

October 26

What is the IMF's Asian Myeloma Network? | Enhancing myeloma care in Asia and globally.

Week in Review

September 7

The First In-Person Patient & Family Seminar in L.A. in 3 Years: A Huge Success

IMF 6th Annual Asian Myeloma Network Summit

Week in Review

October 20

The IMF’s 6th Annual Asian Myeloma Network Summit in Singapore: A Major Success

Week in Review

October 14

Common Sense and Resilience in a Time of Covid

Week in Review

August 13

Global Myeloma Roundtable Guides Understanding of the COVID-19 Crisis

Group photo with members from the IMF'S Asian Myeloma Network

Week in Review

October 25

Second Asian Myeloma Network Summit in Beijing, China Is a Big Success

Week in Review

May 10

The IMF Team in Asia: Connecting With Top Myeloma Experts, Collaborating on New Guidelines, Investigating Promising Research

Share On

Donation

Give Where Most Needed